Pleasanton, CA, United States of America

Eugene Mark Shusterman

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Eugene Mark Shusterman

Introduction

Eugene Mark Shusterman is a notable inventor based in Pleasanton, CA. He has made significant contributions to the field of medical technology, particularly in the area of cerebral autoregulation. With a total of 2 patents to his name, Shusterman's work is paving the way for advancements in patient care.

Latest Patents

Shusterman's latest patents include a Continuous Autoregulation System and a method for the Differentiation of Fluid Volume Change. The Continuous Autoregulation System involves measuring intracranial bioimpedance in a patient's head to evaluate cerebral autoregulation. This method utilizes a Volumetric Integral Phase-Shift Spectroscopy (VIPS) device, which measures the phase shift between magnetic fields to assess the patient's condition. The Differentiation of Fluid Volume Change patent focuses on detecting evidence of a stroke by transmitting signals through the patient's brain using the VIPS device. This innovative approach aims to enhance the accuracy of stroke detection.

Career Highlights

Eugene Mark Shusterman is currently associated with Cerebrotech Medical Systems, Inc., where he continues to develop groundbreaking technologies. His work is instrumental in improving diagnostic methods and patient outcomes in neurology.

Collaborations

Shusterman collaborates with notable professionals in his field, including Mitchell Elliott Levinson and William L. Shea. These partnerships enhance the innovative potential of his projects and contribute to the advancement of medical technology.

Conclusion

Eugene Mark Shusterman's contributions to medical technology through his patents and collaborations are noteworthy. His work is set to make a lasting impact on the field of cerebral autoregulation and stroke detection.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…